 |
3H9J |
Crystal structure of E. coli MccB + AMPCPP + SeMeT MccA |
G |
CD |
|
|
 |
3H9G |
Crystal structure of E. coli MccB + MccA-N7isoASN |
E |
AB |
|
|
 |
3H5R |
Crystal structure of E. coli MccB + Succinimide |
E |
AB |
|
|
 |
3H0A |
Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist |
B |
A |
|
|
 |
3GME |
Crystal Structure of Polynucleotide Phosphorylase in complex with RNase E and manganese |
D |
A |
|
|
 |
3GCM |
Crystal Structure of E. coli polynucleotide phosphorylase bound to RNA and RNase E |
D |
A |
|
|
 |
3G9E |
Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes |
B |
A |
|
|
 |
3G8I |
Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes |
Z |
A |
|
|
 |
3FXV |
Identification of an N-oxide pyridine GW4064 analogue as a potent FXR agonist |
B |
A |
|
|
 |
3FY2 |
Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYEFIW |
B |
A |
|
|
 |
3ET3 |
Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid |
P |
A |
|
|
 |
3ET1 |
Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid |
P |
A |
|
|
 |
3E88 |
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors |
C |
A |
|
|
 |
3E87 |
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors |
C |
A |
|
|
 |
3DNE |
cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24 |
I |
A |
|
|
 |
3DND |
cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24 |
I |
A |
|
|
 |
3DCT |
FXR with SRC1 and GW4064 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3D1F |
Crystal structure of E. coli sliding clamp (beta) bound to a polymerase III peptide |
P |
A |
DNA clamp |
|
 |
3D1E |
Crystal structure of E. coli sliding clamp (beta) bound to a polymerase II peptide |
P |
A |
DNA clamp |
|
 |
3CXW |
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I |
B |
A |
|
|
 |
3CY2 |
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand II |
B |
A |
|
|
 |
3CY3 |
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and the JNK inhibitor V |
B |
A |
|
|
 |
3CQW |
Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
C |
A |
|
|
 |
3CQU |
Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor |
C |
A |
|
|
 |
3CD3 |
Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide |
B |
A |
|
|
 |
3CBL |
Crystal structure of human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide |
B |
A |
|
|
 |
3C5I |
Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520 |
E |
C |
|
|
 |
3BU5 |
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide and ATP |
B |
C |
|
|
 |
3BU3 |
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide |
B |
A |
Protein kinase-like (PK-like) |
|
 |
3BQD |
Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3BEJ |
Structure of human FXR in complex with MFA-1 and co-activator peptide |
E |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZVM |
Crystal structure of PCNA in complex with DNA polymerase iota fragment |
W |
C |
|
|
 |
2VO7 |
STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE |
I |
A |
Protein kinase-like (PK-like) |
|
 |
2VO6 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE |
I |
A |
|
|
 |
2VO3 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE |
I |
A |
|
|
 |
2VO0 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE |
I |
A |
|
|
 |
2VNY |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)AMINE |
I |
A |
|
|
 |
2VNW |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)METHANAMINE |
I |
A |
|
|
 |
2V3S |
STRUCTURAL INSIGHTS INTO THE RECOGNITION OF SUBSTRATES AND ACTIVATORS BY THE OSR1 KINASE |
D |
A |
|
|
 |
2V2F |
CRYSTAL STRUCTURE OF PBP1A FROM DRUG-RESISTANT STRAIN 5204 FROM STREPTOCOCCUS PNEUMONIAE |
A |
F |
|
|
 |
2UZW |
PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS |
I |
E |
|
|
 |
2UZV |
PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS |
2 |
A |
|
|
 |
2UZU |
PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS |
I |
E |
|
|
 |
2UZT |
PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS |
B |
A |
|
|
 |
2UW9 |
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE |
C |
A |
Protein kinase-like (PK-like) |
|
 |
2UW0 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4-(4-CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE |
I |
A |
|
|
 |
2UW3 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4-PHENYL-1H-PYRAZOLE |
I |
A |
|
|
 |
2UW4 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE |
I |
A |
|
|
 |
2UW5 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE |
I |
A |
|
|
 |
2UW6 |
STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE |
I |
A |
|
|